BioNTech SE is 6.8x more valuable than Denali Therapeutics Inc. by market capitalization ($22.18 B vs $3.27 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | DNLI | BNTX |
|---|---|---|
| Market cap | $3.27 B | $22.18 B |
| US-listed rank | #1734 | #582 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$512.54M | - |
| SEC filings | 763 | 548 |
BioNTech SE is 6.8x more valuable than Denali Therapeutics Inc. by market capitalization ($22.18 B vs $3.27 B).
Full pages: Denali Therapeutics Inc. and BioNTech SE, or browse the full rankings.